{"id":"https://openalex.org/W2005641403","doi":"https://doi.org/10.1007/s40259-013-0079-5","title":"Safety and Pharmacokinetics of Escalating Doses of Human Recombinant Nerve Growth Factor Eye Drops in a Double-Masked, Randomized Clinical Trial","display_name":"Safety and Pharmacokinetics of Escalating Doses of Human Recombinant Nerve Growth Factor Eye Drops in a Double-Masked, Randomized Clinical Trial","publication_year":2013,"publication_date":"2013-12-10","ids":{"openalex":"https://openalex.org/W2005641403","doi":"https://doi.org/10.1007/s40259-013-0079-5","mag":"2005641403","pmid":"https://pubmed.ncbi.nlm.nih.gov/24327173","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4030100"},"language":"en","primary_location":{"id":"doi:10.1007/s40259-013-0079-5","doi":"https://doi.org/10.1007/s40259-013-0079-5","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40259-013-0079-5","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40259-013-0079-5.pdf","source":{"id":"https://openalex.org/S143194599","display_name":"BioDrugs","issn_l":"1172-7039","issn":["1172-7039","1173-8804","1179-190X","2195-8351"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BioDrugs","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s40259-013-0079-5.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083326617","display_name":"Mauro P. Ferrari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140932","display_name":"Domp\u00e9 (Italy)","ror":"https://ror.org/04erezm33","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210140932"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Mauro P. Ferrari","raw_affiliation_strings":["Clinical Development, Domp\u00e9 s.p.a., Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development, Domp\u00e9 s.p.a., Milan, Italy","institution_ids":["https://openalex.org/I4210140932"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013431023","display_name":"Flavio Mantelli","orcid":"https://orcid.org/0000-0003-3459-4866","observed_orcids":["https://orcid.org/0000-0003-3459-4866"]},"institutions":[{"id":"https://openalex.org/I4210100727","display_name":"Fondazione G.B. Bietti","ror":"https://ror.org/012khpt30","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210100727","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Flavio Mantelli","raw_affiliation_strings":["IRCCS Fondazione Bietti, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IRCCS Fondazione Bietti, Rome, Italy","institution_ids":["https://openalex.org/I4210100727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106128689","display_name":"Marta Sacchetti","orcid":"https://orcid.org/0000-0001-5569-778X","observed_orcids":["https://orcid.org/0000-0001-5569-778X"]},"institutions":[{"id":"https://openalex.org/I4210133214","display_name":"IRCCS Ospedale San Raffaele","ror":"https://ror.org/039zxt351","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210133214","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marta Sacchetti","raw_affiliation_strings":["Cornea and Ocular Surface Unit, San Raffaele Hospital, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cornea and Ocular Surface Unit, San Raffaele Hospital, Milan, Italy","institution_ids":["https://openalex.org/I4210133214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028159529","display_name":"Maria Irene Antonangeli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140932","display_name":"Domp\u00e9 (Italy)","ror":"https://ror.org/04erezm33","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210140932"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Irene Antonangeli","raw_affiliation_strings":["Process and Analytical Development, Domp\u00e9 SpA, L\u2019Aquila, Italy","Domp\u00e9 SpA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Process and Analytical Development, Domp\u00e9 SpA, L\u2019Aquila, Italy","institution_ids":["https://openalex.org/I4210140932"]},{"raw_affiliation_string":"Domp\u00e9 SpA","institution_ids":["https://openalex.org/I4210140932"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053503661","display_name":"Franca Cattani","orcid":"https://orcid.org/0000-0002-3873-9295","observed_orcids":["https://orcid.org/0000-0002-3873-9295"]},"institutions":[{"id":"https://openalex.org/I4210140932","display_name":"Domp\u00e9 (Italy)","ror":"https://ror.org/04erezm33","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210140932"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Franca Cattani","raw_affiliation_strings":["Process and Analytical Development, Domp\u00e9 SpA, L\u2019Aquila, Italy","Domp\u00e9 SpA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Process and Analytical Development, Domp\u00e9 SpA, L\u2019Aquila, Italy","institution_ids":["https://openalex.org/I4210140932"]},{"raw_affiliation_string":"Domp\u00e9 SpA","institution_ids":["https://openalex.org/I4210140932"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003134117","display_name":"Gaetano D\u2019Anniballe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140932","display_name":"Domp\u00e9 (Italy)","ror":"https://ror.org/04erezm33","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210140932"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Gaetano D\u2019Anniballe","raw_affiliation_strings":["Process and Analytical Development, Domp\u00e9 SpA, L\u2019Aquila, Italy","Domp\u00e9 SpA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Process and Analytical Development, Domp\u00e9 SpA, L\u2019Aquila, Italy","institution_ids":["https://openalex.org/I4210140932"]},{"raw_affiliation_string":"Domp\u00e9 SpA","institution_ids":["https://openalex.org/I4210140932"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044632482","display_name":"Francesco Sinigaglia","orcid":"https://orcid.org/0000-0002-0639-8043","observed_orcids":["https://orcid.org/0000-0002-0639-8043"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francesco Sinigaglia","raw_affiliation_strings":["Anabasis Srl, Milan, Italy","Anabasis Srl"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anabasis Srl, Milan, Italy","institution_ids":[]},{"raw_affiliation_string":"Anabasis Srl","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030609859","display_name":"Pier Adelchi Ruffini","orcid":"https://orcid.org/0000-0001-9492-9627","observed_orcids":["https://orcid.org/0000-0001-9492-9627"]},"institutions":[{"id":"https://openalex.org/I4210140932","display_name":"Domp\u00e9 (Italy)","ror":"https://ror.org/04erezm33","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210140932"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Pier Adelchi Ruffini","raw_affiliation_strings":["Clinical Development, Domp\u00e9 s.p.a., Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development, Domp\u00e9 s.p.a., Milan, Italy","institution_ids":["https://openalex.org/I4210140932"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081222861","display_name":"Alessandro Lamb\u00ecase","orcid":"https://orcid.org/0000-0002-8974-991X","observed_orcids":["https://orcid.org/0000-0002-8974-991X"]},"institutions":[{"id":"https://openalex.org/I155125353","display_name":"Universit\u00e0 Campus Bio-Medico","ror":"https://ror.org/04gqx4x78","country_code":"IT","type":"education","lineage":["https://openalex.org/I155125353"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Alessandro Lambiase","raw_affiliation_strings":["Department of Ophthalmology, Campus Bio-Medico University of Rome, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Campus Bio-Medico University of Rome, Rome, Italy","institution_ids":["https://openalex.org/I155125353"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5081222861"],"corresponding_institution_ids":["https://openalex.org/I155125353"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":{"value":5190,"currency":"USD","value_usd":5190},"fwci":4.5023,"has_fulltext":true,"cited_by_count":78,"citation_normalized_percentile":{"value":0.93922933,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"28","issue":"3","first_page":"275","last_page":"283"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10997","display_name":"Ocular Surface and Contact Lens","score":0.7192000150680542,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10997","display_name":"Ocular Surface and Contact Lens","score":0.7192000150680542,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.0771000012755394,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.06120000034570694,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nerve-growth-factor","display_name":"nerve growth factor","score":0.9769999980926514},{"id":"https://openalex.org/keywords/eye-drops","display_name":"eye drops","score":0.921999990940094},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7720000147819519},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.8870000243186951},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.675000011920929},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7239999771118164},{"id":"https://openalex.org/keywords/antidrug-antibodies","display_name":"antidrug antibodies","score":0.7409999966621399},{"id":"https://openalex.org/keywords/ocular-side-effects","display_name":"ocular adverse effects","score":0.8960000276565552},{"id":"https://openalex.org/keywords/tear-function","display_name":"tear function","score":0.6800000071525574},{"id":"https://openalex.org/keywords/intraocular-pressure","display_name":"intraocular pressure","score":0.9589999914169312},{"id":"https://openalex.org/keywords/neurotrophins","display_name":"neurotrophins","score":0.6959999799728394},{"id":"https://openalex.org/keywords/ophthalmic-drug-development","display_name":"ophthalmic drug development","score":0.7440000176429749}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8926094174385071},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6112951636314392},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5617262125015259},{"id":"https://openalex.org/C2778423431","wikidata":"https://www.wikidata.org/wiki/Q417782","display_name":"Nerve growth factor","level":3,"score":0.5609580874443054},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.47790274024009705},{"id":"https://openalex.org/C2778257484","wikidata":"https://www.wikidata.org/wiki/Q555066","display_name":"Visual acuity","level":2,"score":0.47013622522354126},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4551326334476471},{"id":"https://openalex.org/C2781092963","wikidata":"https://www.wikidata.org/wiki/Q650050","display_name":"Intraocular pressure","level":2,"score":0.4470392167568207},{"id":"https://openalex.org/C2776391266","wikidata":"https://www.wikidata.org/wiki/Q9612","display_name":"Fundus (uterus)","level":2,"score":0.4267827868461609},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.35615861415863037},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3308243155479431},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.07463023066520691}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005128","descriptor_name":"Eye Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009414","descriptor_name":"Nerve Growth Factors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009414","descriptor_name":"Nerve Growth Factors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D009414","descriptor_name":"Nerve Growth Factors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D009883","descriptor_name":"Ophthalmic Solutions","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009883","descriptor_name":"Ophthalmic Solutions","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D009883","descriptor_name":"Ophthalmic Solutions","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.1007/s40259-013-0079-5","doi":"https://doi.org/10.1007/s40259-013-0079-5","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40259-013-0079-5","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40259-013-0079-5.pdf","source":{"id":"https://openalex.org/S143194599","display_name":"BioDrugs","issn_l":"1172-7039","issn":["1172-7039","1173-8804","1179-190X","2195-8351"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BioDrugs","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3005217","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC4030100","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmid:24327173","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24327173","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4030100","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4030100/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BioDrugs","raw_type":"Text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.815.4050","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.815.4050","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/32/e2/40259_2013_Article_79.PMC4030100.pdf","raw_type":"text"},{"id":"pmh:oai:iris.uniroma1.it:11573/548500","doi":null,"is_oa":false,"landing_page_url":"http://rd.springer.com/journal/40259","pdf_url":null,"source":{"id":"https://openalex.org/S4377196107","display_name":"IRIS Research product catalog (Sapienza University of Rome)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1007/s40259-013-0079-5","doi":"https://doi.org/10.1007/s40259-013-0079-5","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40259-013-0079-5","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40259-013-0079-5.pdf","source":{"id":"https://openalex.org/S143194599","display_name":"BioDrugs","issn_l":"1172-7039","issn":["1172-7039","1173-8804","1179-190X","2195-8351"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BioDrugs","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2005641403.pdf","grobid_xml":"https://content.openalex.org/works/W2005641403.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W1583718643","https://openalex.org/W1982449957","https://openalex.org/W1982551390","https://openalex.org/W1994052806","https://openalex.org/W2003522028","https://openalex.org/W2026004539","https://openalex.org/W2052148907","https://openalex.org/W2052751137","https://openalex.org/W2058199689","https://openalex.org/W2063695629","https://openalex.org/W2065662892","https://openalex.org/W2078006048","https://openalex.org/W2082739481","https://openalex.org/W2120646453","https://openalex.org/W2122945372","https://openalex.org/W2130337257","https://openalex.org/W2132374129","https://openalex.org/W2140969998","https://openalex.org/W2149951068","https://openalex.org/W2159799352","https://openalex.org/W2167392643","https://openalex.org/W2318073942","https://openalex.org/W2337729957","https://openalex.org/W2410146618","https://openalex.org/W2976216518"],"related_works":["https://openalex.org/W7096436812","https://openalex.org/W4415064286","https://openalex.org/W1018318268","https://openalex.org/W2080116022","https://openalex.org/W4321501084","https://openalex.org/W2933338902","https://openalex.org/W4307262096","https://openalex.org/W3212255874","https://openalex.org/W2126593848","https://openalex.org/W2278845798"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1],"OBJECTIVES:":[2],"Nerve":[3],"growth":[4],"factor":[5],"(NGF)":[6],"is":[7],"a":[8,33,42,84,95,105,122,132,186,207],"neurotrophin":[9],"with":[10,231],"therapeutic":[11],"possibilities":[12],"that":[13],"extend":[14],"from":[15],"the":[16,20,24,221,242,245],"nervous":[17],"system":[18],"to":[19,81,214],"eye.":[21],"We":[22],"tested":[23],"safety,":[25],"maximal":[26],"tolerated":[27],"dose,":[28],"pharmacokinetics,":[29],"and":[30,160,173,193,206],"antigenicity":[31],"of":[32,99,126,178,189,236,247],"novel":[34],"human":[35],"recombinant":[36],"NGF":[37,157,191],"(rhNGF)":[38],"eye-drop":[39,86],"formulation":[40],"in":[41,78,185,199,252],"phase":[43],"I":[44],"study.":[45],"METHODS:":[46],"This":[47],"prospective,":[48],"randomized,":[49],"double-masked,":[50],"vehicle-controlled":[51],"trial,":[52],"sponsored":[53],"by":[54],"Domp\u00e9":[55],"SpA":[56],"(registered":[57],"as":[58],"NCT01744704":[59],"at":[60,220],"ClinicalTrials.gov),":[61],"enrolled":[62],"74":[63],"healthy":[64],"volunteers":[65],"(24":[66],"females,":[67],"50":[68],"males,":[69],"age":[70],"40.2":[71],"\u00b1":[72],"11.8":[73],"years).":[74],"Subjects":[75],"were":[76,197,204,217,228],"randomized":[77],"three":[79,103,130],"cohorts":[80],"receive":[82],"(1)":[83],"single":[85,96],"containing":[87],"0.0175,":[88],"0.175,":[89],"or":[90,115,118,120,141,144],"0.7":[91],"\u03bcg":[92],"rhNGF;":[93],"(2)":[94],"ascending":[97,124],"dose":[98,112,125,138],"rhNGF":[100,127,179,215,225,251],"eye":[101,128,180,226],"drops":[102,129,181,227],"times":[104,131],"day":[106,109,133],"for":[107,134,244],"1":[108],"(total":[110,137],"daily":[111],"2.1,":[113],"6.3,":[114],"18.9":[116],"\u03bcg),":[117,143],"vehicle;":[119],"(3)":[121],"multiple":[123],"5":[135],"days":[136],"10.5,":[139],"31.5,":[140],"94.5":[142],"vehicle.":[145],"Outcome":[146],"measures":[147],"included":[148],"blood":[149],"chemistry,":[150],"urinalyses,":[151],"vital":[152],"signs,":[153],"electrocardiograms":[154],"(ECGs),":[155],"serum":[156],"antibodies,":[158],"ocular":[159,174,211],"systemic":[161,237],"adverse":[162],"events":[163],"(AEs),":[164],"visual":[165],"acuity,":[166],"tear":[167],"function,":[168],"intraocular":[169],"pressure,":[170],"fundus":[171],"oculi,":[172],"symptoms.":[175],"RESULTS:":[176],"Administration":[177],"did":[182],"not":[183],"result":[184],"significant":[187],"increase":[188],"circulating":[190],"levels":[192],"no":[194,232],"antidrug":[195],"antibodies":[196],"detected":[198],"serum.":[200],"No":[201],"serious":[202],"AEs":[203,212],"recorded,":[205],"few":[208],"mild,":[209],"transient":[210],"related":[213],"administration":[216],"reported":[218],"only":[219],"highest":[222],"concentration.":[223],"CONCLUSIONS:":[224],"well":[229],"tolerated,":[230],"detectable":[233],"clinical":[234,248],"evidence":[235],"AEs.":[238],"These":[239],"results":[240],"pave":[241],"way":[243],"development":[246],"trials":[249],"on":[250],"ophthalmology.":[253]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}